Invitation to speak and join panel discussion at the NLSDays

MonTa Biosciences is invited to speak and join panel discussion with major Big Pharma companies Roche [...]

MonTa Biosciences attend Bio in Boston

MonTa Biosciences attend Bio in Boston from June 4-7th to meet and discuss partnership, collaborations and investment opportunities. Send [...]

The AngloNordic Life science conference

MonTa Biosciences attend the AngloNordic Life science conference in London on Mya 24th to meet investors and network [...]

Attending the Biotechandmoney conference

MonTa Biosciences attend the Biotechandmoney conference in London on February 5-6. [...]

BioEurope partnering conference in Berlin

MonTa Biosciences attends the BioEurope partnering conference in Berlin from November 4-8. Please book a meeting with [...]

Completion of license agreements

MonTa Biosciences announces completion of license agreements with UC San Diego and Danish Technical University. The immune [...]

Nordic Life Science Days in Malmö

MonTa Biosciences attends the Nordic Life Science Days in Malmö to meet with investors and pharma partners. [...]

Esper Boel joins Board of Directors

MonTa Biosciences recruits PhD, Esper Boel former SVP in Novo Nordisk and strategic adviosor in immunotherapy to its Board [...]

BioEurope Spring in Barcelona

MonTa Biosciences attends BioEurope Spring in Barcelona to have meetings with more than 10 of the top [...]

Investment from Pre-Seed Innovation

MonTa Biosciences closes an investment from Pre-Seed Innovation to reach key milestones for our cancer [...]

Joining the NOME Mentoring programme

MonTa Biosciences join the NOME Mentoring programme in the North Carolina Research Triangle and are appointed top [...]

MonTa Biosciences included in the NOME Nordic Mentoring Network for Entrepreneurship

MonTa Biosciences awarded to be included in the NOME Nordic Mentoring Network for Entrepreneurship. MonTa Biosciences is priviledged to be part [...]

Article published by the Danish Biotech media, Medwatch

A news article was published by the Danish Biotech media; Medwatch on the newly granted [...]

Granted an Investment from “Innovationsfonden”

MonTa Biosciences is part of the XVac “Grand Solutions”  granted an Investment from “Innovationsfonden”. The XVac project [...]

Co-founder Thomas L Andresen talks in Danish national radio

MonTa Biosciences Co-founder Thomas L Andresen talks in Danish national radio about the cancer immunotehrapy [...]

MedWatch publishes article

MedWatch publishes article on MonTa Biosciences. [...]

Monocyte targeting technology published

The monocyte targeting technology was published in an article in  “Expert Opinion in Drug Delivery”. [...]

Awarded a “Proof-of-Concept” grant from Copenhagen Spin-puts

MonTa Biosciences was awarded a “Proof-of-Concept” grant from Copenhagen Spin-puts” to support the early development [...]

Article published in Medwatch

An article about MonTa Biosciences was published in Medwatch on April 8, 2014. [...]

Technology presented at the “SITC” in Washington DC

The MonTa Biosciences’ technology was presented at the Society for Immunotherapy of Cancer “SITC” in National harbour, [...]